AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome

Peng Li, Thomas White, Wei Xie, Wei Cui, Deniz Peker, Gang Zeng, Huan You Wang, Jennie Vagher, Sara Brown, Margaret Williams, Tibor Kovacsovics, Jay L. Patel

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome'. Together they form a unique fingerprint.

Medicine & Life Sciences